Oct 21, 2019 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Bavarian Nordic Q&A session. (Operator Instructions) Please be advised that this conference is being recorded. (Operator Instructions)
I'd now like to hand the conference over to your speaker today, Mr. Rolf Sass, CEO (sic) [Vice President, Investor Relations].
Rolf Sass Sørensen - Bavarian Nordic A/S-VP of IR&Communications
Thank you, and welcome to this conference regarding Bavarian Nordic's acquisition of 2 commercial vaccines from GSK. With me, I have our Chief Financial Officer, Henrik Juuel; as well as our President and CEO, Paul Chaplin.
Before we start, I need to read the forward-looking statements. This presentation includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside our control, that could cause actual results to differ materially from the results discussed.
Forward-looking statements include statements regarding our
Bavarian Nordic A/S - Special Call Transcript
Oct 21, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers